Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILB in ALS/MND
NCT03705390Phase 2Terminated
- Sponsor
- University of Birmingham
- Start
- Mar 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ilb in amyotrophic lateral sclerosis (ALS), sponsored by University of Birmingham. Started Mar 2019; status: terminated.
02
Drugs
ilb
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03705390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705390.